Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

Demirci, Emre; Kabasakal, Levent; Sahin, Onur E; Akgün, Elife; Gültekin, Mehmet Hamza; Doganca, Tünkut; Tuna, Mustafa B; Öbek, Can; Kiliç, Mert; Esen, Tarik; Kural, Ali R

Demirci, Emre; Kabasakal, Levent; Sahin, Onur E; Akgün, Elife; Gültekin, Mehmet Hamza; Doganca, Tünkut; Tuna, Mustafa B; Öbek, Can; Kiliç, Mert; Esen, Tarik; Kural, Ali R.

Affiliation

Demirci E; Department of Nuclear Medicine, Yeditepe University Medical Faculty.
Kabasakal L; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University.
Sahin OE; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University.
Akgün E; Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University.
Gültekin MH; Department of Urology, Cerrahpasa Medical Faculty University.
Doganca T; Department of Urology/Uro-Onkology, Acibadem Health Group, Taksim Hospital.
Tuna MB; Department of Urology, Acibadem Health Group, Maslak Hospital.
Öbek C; Department of Urology/Uro-Onkology, Acibadem Health Group, Taksim Hospital.
Kiliç M; Department of Urology, V.K.V. American Hospital.
Esen T; Department of Urology, Koç University Medical Faculty.
Kural AR; Department of Urology, Acibadem University Medical Faculty, Istanbul, Turkey.

Nucl Med Commun ; 40(1): 86-91, 2019 Jan.

Article de En | MEDLINE | ID: mdl-30395048

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Oligopeptides / Tumeurs de la prostate / Acide édétique / Tomographie par émission de positons couplée à la tomodensitométrie Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Humans / Male / Middle aged Langue: En Journal: Nucl Med Commun Année: 2019 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google